These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18540369)

  • 1. [Combination therapy with methylprednisolone (mPSL) and high-dose immunoglobulin (IVIg)].
    Nishida H; Kuroda T; Wakita K
    Nihon Rinsho; 2008 Jun; 66(6):1190-4. PubMed ID: 18540369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical variants of Guillain-Barre syndrome: some aspects of differential diagnosis.
    Dididze MN
    Georgian Med News; 2009 Jan; (166):48-51. PubMed ID: 19202218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of Guillain-Barre syndrome in children: results from a Mexican population.
    Nachamkin I; Arzarte Barbosa P; Ung H; Lobato C; Gonzalez Rivera A; Rodriguez P; Garcia Briseno A; Cordero LM; Garcia Perea L; Perez JC; Ribera M; Aldama PC; Guitérrez GD; Sarnat LF; García MR; Veitch J; Fitzgerald C; Cornblath DR; Rodriguez Pinto M; Griffin JW; Willison HJ; Asbury AK; McKhann GM
    Neurology; 2007 Oct; 69(17):1665-71. PubMed ID: 17898327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Guillain-Barré syndrome in childhood].
    Kollár K; Liptai Z; Rosdy B; Móser J
    Ideggyogy Sz; 2009 Nov; 62(11-12):399-404. PubMed ID: 20025130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of immunoglobulin in severe childhood Guillain-Barré syndrome.
    Ortiz-Corredor F; Peña-Preciado M
    Acta Neurol Scand; 2007 Apr; 115(4):289-93. PubMed ID: 17376129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenously administered immunoglobulin in the treatment of childhood Guillain-Barré syndrome: a randomized trial.
    Korinthenberg R; Schessl J; Kirschner J; Mönting JS
    Pediatrics; 2005 Jul; 116(1):8-14. PubMed ID: 15995024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in lymphocyte subsets in patients with Guillain-Barré syndrome treated with immunoglobulin.
    Hou HQ; Miao J; Feng XD; Han M; Song XJ; Guo L
    BMC Neurol; 2014 Oct; 14():202. PubMed ID: 25315010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of Guillain-Barré syndrome following intravenous immunoglobulin compared to natural course.
    Kalita J; Misra UK; Chaudhary SK; Das M; Mishra A; Ranjan A; Kumar M
    Eur J Neurol; 2022 Oct; 29(10):3071-3080. PubMed ID: 35837807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of childhood acute immune thrombocytopenic purpura with high-dose methylprednisolone, intravenous immunoglobulin, or the combination of both.
    Gereige RS; Barrios NJ
    P R Health Sci J; 2000 Mar; 19(1):15-8. PubMed ID: 10761200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS).
    van Doorn PA
    Presse Med; 2013 Jun; 42(6 Pt 2):e193-201. PubMed ID: 23628447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Guillain-Barre syndrome and its frontiers].
    Azulay JP; Verschueren A; Attarian S; Pouget J
    Rev Neurol (Paris); 2002 Dec; 158(12 Pt 2):S21-6. PubMed ID: 12690657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological subtypes and prognosis of childhood Guillain-Barré syndrome in Japan.
    Nagasawa K; Kuwabara S; Misawa S; Fujii K; Tanabe Y; Yuki N; Hattori T; Kohno Y
    Muscle Nerve; 2006 Jun; 33(6):766-70. PubMed ID: 16506153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial.
    van Koningsveld R; Schmitz PI; Meché FG; Visser LH; Meulstee J; van Doorn PA;
    Lancet; 2004 Jan; 363(9404):192-6. PubMed ID: 14738791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome.
    Kuitwaard K; de Gelder J; Tio-Gillen AP; Hop WC; van Gelder T; van Toorenenbergen AW; van Doorn PA; Jacobs BC
    Ann Neurol; 2009 Nov; 66(5):597-603. PubMed ID: 19938102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Guillain-Barré syndrome with high-dose immune globulins combined with methylprednisolone: a pilot study. The Dutch Guillain-Barré Study Group.
    Ann Neurol; 1994 Jun; 35(6):749-52. PubMed ID: 8210234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of intravenous immunoglobulin retreatment amongst Guillain-Barré syndrome patients who poorly responded to initial IVIG cycle: a systematic review.
    Prado MB; Adiao KJB; Turalde CWR; Dasig DA
    Acta Neurol Belg; 2024 Aug; 124(4):1237-1250. PubMed ID: 38553651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J
    Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired inflammatory demyelinating neuropathies.
    Ensrud ER; Krivickas LS
    Phys Med Rehabil Clin N Am; 2001 May; 12(2):321-34, ix. PubMed ID: 11345010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second IVIg course in Guillain-Barré syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial.
    Walgaard C; Jacobs BC; Lingsma HF; Steyerberg EW; Cornblath DR; van Doorn PA;
    J Peripher Nerv Syst; 2018 Dec; 23(4):210-215. PubMed ID: 30151941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Guillain-Barré syndrome and CIDP.
    van Doorn PA
    J Peripher Nerv Syst; 2005 Jun; 10(2):113-27. PubMed ID: 15958124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.